Endoscopic ultrasound-guided hepaticogastrostomy versus percutaneous transhepatic drainage for malignant biliary obstruction after failed endoscopic retrograde cholangiopancreatography: a retrospective expertise-based study from two centers
Background: Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of the common bile duct (CBD) after failed endoscopic retrograde cholangiopancreatography (ERCP) or in case of surgically altered anatomy. Endo...
Uložené v:
| Vydané v: | Therapeutic advances in gastroenterology Ročník 10; číslo 6; s. 483 - 493 |
|---|---|
| Hlavní autori: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London, England
SAGE Publications
01.06.2017
Sage Publications Ltd Sage Publishing |
| Predmet: | |
| ISSN: | 1756-2848, 1756-283X, 1756-2848 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background:
Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of the common bile duct (CBD) after failed endoscopic retrograde cholangiopancreatography (ERCP) or in case of surgically altered anatomy. Endoscopic ultrasound-guided hepaticogastrostomy (EU-HGS) is a more recently introduced alternative to relieve malignant obstructive jaundice. The aim of this prospective observational study was to compare the outcome, efficacy and adverse events of EU-HGS and PTBD.
Methods:
From April 2012 to August 2015, consecutive patients with malignant CBD obstruction who underwent EU-HGS or PTBD in two tertiary-care referral centers were included. The primary endpoint was the clinical success rate. Secondary endpoints were technical success, overall survival, procedure-related adverse events, incidence of adverse events, and reintervention rate.
Results:
A total of 51 patients (EU-HGS, n = 31; PTBD, n = 20) were included. Median survival was 71 days (range 25–75th percentile; 30–95) for the EU-HGS group and 78 days (range 25–75th percentile; 42–108) for the PTBD group (p = 0.99). Technical success was achieved in all patients in both groups. Clinical success was achieved in 25 (86%) of 31 patients in the EU-HGS group and in 15 (83%) of 20 patients in the PTBD group (p = 0.88). There was no difference in adverse events rates between the two groups (EU-HGS: 16%; PTBD: 10%) (p = 0.69). Four deaths within 1 month (two hemorrhagic and two septic) were considered procedure related (two in the EU-HGS group and two in the PTBD group). Overall reintervention rate was significantly lower after EU-HGS (n = 2) than after PTBD (n = 21) (p = 0.0001). Length of hospital stay was shorter after EU-HGS (8 days versus 15 days; p = 0.002).
Conclusions:
EU-HGS can be an effective and safe mini invasive-procedure alternative to PTBD, with similar success and adverse-event rates, but with lower rates of reintervention and length of hospitalization. |
|---|---|
| AbstractList | Background:
Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of the common bile duct (CBD) after failed endoscopic retrograde cholangiopancreatography (ERCP) or in case of surgically altered anatomy. Endoscopic ultrasound-guided hepaticogastrostomy (EU-HGS) is a more recently introduced alternative to relieve malignant obstructive jaundice. The aim of this prospective observational study was to compare the outcome, efficacy and adverse events of EU-HGS and PTBD.
Methods:
From April 2012 to August 2015, consecutive patients with malignant CBD obstruction who underwent EU-HGS or PTBD in two tertiary-care referral centers were included. The primary endpoint was the clinical success rate. Secondary endpoints were technical success, overall survival, procedure-related adverse events, incidence of adverse events, and reintervention rate.
Results:
A total of 51 patients (EU-HGS, n = 31; PTBD, n = 20) were included. Median survival was 71 days (range 25–75th percentile; 30–95) for the EU-HGS group and 78 days (range 25–75th percentile; 42–108) for the PTBD group (p = 0.99). Technical success was achieved in all patients in both groups. Clinical success was achieved in 25 (86%) of 31 patients in the EU-HGS group and in 15 (83%) of 20 patients in the PTBD group (p = 0.88). There was no difference in adverse events rates between the two groups (EU-HGS: 16%; PTBD: 10%) (p = 0.69). Four deaths within 1 month (two hemorrhagic and two septic) were considered procedure related (two in the EU-HGS group and two in the PTBD group). Overall reintervention rate was significantly lower after EU-HGS (n = 2) than after PTBD (n = 21) (p = 0.0001). Length of hospital stay was shorter after EU-HGS (8 days versus 15 days; p = 0.002).
Conclusions:
EU-HGS can be an effective and safe mini invasive-procedure alternative to PTBD, with similar success and adverse-event rates, but with lower rates of reintervention and length of hospitalization. Background: Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of the common bile duct (CBD) after failed endoscopic retrograde cholangiopancreatography (ERCP) or in case of surgically altered anatomy. Endoscopic ultrasound-guided hepaticogastrostomy (EU-HGS) is a more recently introduced alternative to relieve malignant obstructive jaundice. The aim of this prospective observational study was to compare the outcome, efficacy and adverse events of EU-HGS and PTBD. Methods: From April 2012 to August 2015, consecutive patients with malignant CBD obstruction who underwent EU-HGS or PTBD in two tertiary-care referral centers were included. The primary endpoint was the clinical success rate. Secondary endpoints were technical success, overall survival, procedure-related adverse events, incidence of adverse events, and reintervention rate. Results: A total of 51 patients (EU-HGS, n = 31; PTBD, n = 20) were included. Median survival was 71 days (range 25–75th percentile; 30–95) for the EU-HGS group and 78 days (range 25–75th percentile; 42–108) for the PTBD group (p = 0.99). Technical success was achieved in all patients in both groups. Clinical success was achieved in 25 (86%) of 31 patients in the EU-HGS group and in 15 (83%) of 20 patients in the PTBD group (p = 0.88). There was no difference in adverse events rates between the two groups (EU-HGS: 16%; PTBD: 10%) (p = 0.69). Four deaths within 1 month (two hemorrhagic and two septic) were considered procedure related (two in the EU-HGS group and two in the PTBD group). Overall reintervention rate was significantly lower after EU-HGS (n = 2) than after PTBD (n = 21) (p = 0.0001). Length of hospital stay was shorter after EU-HGS (8 days versus 15 days; p = 0.002). Conclusions: EU-HGS can be an effective and safe mini invasive-procedure alternative to PTBD, with similar success and adverse-event rates, but with lower rates of reintervention and length of hospitalization. Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of the common bile duct (CBD) after failed endoscopic retrograde cholangiopancreatography (ERCP) or in case of surgically altered anatomy. Endoscopic ultrasound-guided hepaticogastrostomy (EU-HGS) is a more recently introduced alternative to relieve malignant obstructive jaundice. The aim of this prospective observational study was to compare the outcome, efficacy and adverse events of EU-HGS and PTBD.BACKGROUNDPercutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of the common bile duct (CBD) after failed endoscopic retrograde cholangiopancreatography (ERCP) or in case of surgically altered anatomy. Endoscopic ultrasound-guided hepaticogastrostomy (EU-HGS) is a more recently introduced alternative to relieve malignant obstructive jaundice. The aim of this prospective observational study was to compare the outcome, efficacy and adverse events of EU-HGS and PTBD.From April 2012 to August 2015, consecutive patients with malignant CBD obstruction who underwent EU-HGS or PTBD in two tertiary-care referral centers were included. The primary endpoint was the clinical success rate. Secondary endpoints were technical success, overall survival, procedure-related adverse events, incidence of adverse events, and reintervention rate.METHODSFrom April 2012 to August 2015, consecutive patients with malignant CBD obstruction who underwent EU-HGS or PTBD in two tertiary-care referral centers were included. The primary endpoint was the clinical success rate. Secondary endpoints were technical success, overall survival, procedure-related adverse events, incidence of adverse events, and reintervention rate.A total of 51 patients (EU-HGS, n = 31; PTBD, n = 20) were included. Median survival was 71 days (range 25-75th percentile; 30-95) for the EU-HGS group and 78 days (range 25-75th percentile; 42-108) for the PTBD group (p = 0.99). Technical success was achieved in all patients in both groups. Clinical success was achieved in 25 (86%) of 31 patients in the EU-HGS group and in 15 (83%) of 20 patients in the PTBD group (p = 0.88). There was no difference in adverse events rates between the two groups (EU-HGS: 16%; PTBD: 10%) (p = 0.69). Four deaths within 1 month (two hemorrhagic and two septic) were considered procedure related (two in the EU-HGS group and two in the PTBD group). Overall reintervention rate was significantly lower after EU-HGS (n = 2) than after PTBD (n = 21) (p = 0.0001). Length of hospital stay was shorter after EU-HGS (8 days versus 15 days; p = 0.002).RESULTSA total of 51 patients (EU-HGS, n = 31; PTBD, n = 20) were included. Median survival was 71 days (range 25-75th percentile; 30-95) for the EU-HGS group and 78 days (range 25-75th percentile; 42-108) for the PTBD group (p = 0.99). Technical success was achieved in all patients in both groups. Clinical success was achieved in 25 (86%) of 31 patients in the EU-HGS group and in 15 (83%) of 20 patients in the PTBD group (p = 0.88). There was no difference in adverse events rates between the two groups (EU-HGS: 16%; PTBD: 10%) (p = 0.69). Four deaths within 1 month (two hemorrhagic and two septic) were considered procedure related (two in the EU-HGS group and two in the PTBD group). Overall reintervention rate was significantly lower after EU-HGS (n = 2) than after PTBD (n = 21) (p = 0.0001). Length of hospital stay was shorter after EU-HGS (8 days versus 15 days; p = 0.002).EU-HGS can be an effective and safe mini invasive-procedure alternative to PTBD, with similar success and adverse-event rates, but with lower rates of reintervention and length of hospitalization.CONCLUSIONSEU-HGS can be an effective and safe mini invasive-procedure alternative to PTBD, with similar success and adverse-event rates, but with lower rates of reintervention and length of hospitalization. Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of the common bile duct (CBD) after failed endoscopic retrograde cholangiopancreatography (ERCP) or in case of surgically altered anatomy. Endoscopic ultrasound-guided hepaticogastrostomy (EU-HGS) is a more recently introduced alternative to relieve malignant obstructive jaundice. The aim of this prospective observational study was to compare the outcome, efficacy and adverse events of EU-HGS and PTBD. From April 2012 to August 2015, consecutive patients with malignant CBD obstruction who underwent EU-HGS or PTBD in two tertiary-care referral centers were included. The primary endpoint was the clinical success rate. Secondary endpoints were technical success, overall survival, procedure-related adverse events, incidence of adverse events, and reintervention rate. A total of 51 patients (EU-HGS, = 31; PTBD, = 20) were included. Median survival was 71 days (range 25-75th percentile; 30-95) for the EU-HGS group and 78 days (range 25-75th percentile; 42-108) for the PTBD group ( = 0.99). Technical success was achieved in all patients in both groups. Clinical success was achieved in 25 (86%) of 31 patients in the EU-HGS group and in 15 (83%) of 20 patients in the PTBD group ( = 0.88). There was no difference in adverse events rates between the two groups (EU-HGS: 16%; PTBD: 10%) ( = 0.69). Four deaths within 1 month (two hemorrhagic and two septic) were considered procedure related (two in the EU-HGS group and two in the PTBD group). Overall reintervention rate was significantly lower after EU-HGS ( = 2) than after PTBD ( = 21) ( = 0.0001). Length of hospital stay was shorter after EU-HGS (8 days 15 days; = 0.002). EU-HGS can be an effective and safe mini invasive-procedure alternative to PTBD, with similar success and adverse-event rates, but with lower rates of reintervention and length of hospitalization. |
| Author | Greget, Michel Coriat, Romain Grabar, Sophie Sportes, Adrien Camus, Marine Leblanc, Sarah Prat, Frédéric Hochberger, Jürgen Chaussade, Stanislas |
| Author_xml | – sequence: 1 givenname: Adrien surname: Sportes fullname: Sportes, Adrien organization: Gastroenterology Unit, Hôpital Cochin (AP-HP), University Paris Descartes, Paris, France – sequence: 2 givenname: Marine surname: Camus fullname: Camus, Marine organization: Gastroenterology Unit, Hôpital Cochin (AP-HP), University Paris Descartes, Paris, France – sequence: 3 givenname: Michel surname: Greget fullname: Greget, Michel organization: Interventional Radiology Unit CHRU Strasbourg, University of Strasbourg, France – sequence: 4 givenname: Sarah surname: Leblanc fullname: Leblanc, Sarah organization: Gastroenterology Unit, Hôpital Cochin (AP-HP), University Paris Descartes, Paris, France – sequence: 5 givenname: Romain surname: Coriat fullname: Coriat, Romain organization: Gastroenterology Unit, Hôpital Cochin (AP-HP), University Paris Descartes, Paris, France – sequence: 6 givenname: Jürgen surname: Hochberger fullname: Hochberger, Jürgen organization: Gastroenterology Unit, Nouvel Hôpital Civil CHRU Strasbourg, University of Strasbourg, France – sequence: 7 givenname: Stanislas surname: Chaussade fullname: Chaussade, Stanislas organization: Gastroenterology Unit, Hôpital Cochin (AP-HP), University Paris Descartes, Paris, France – sequence: 8 givenname: Sophie surname: Grabar fullname: Grabar, Sophie organization: Biostatistics and Epidemiology, Hôtel Dieu (AP-HP), University Paris Descartes, Paris, France – sequence: 9 givenname: Frédéric surname: Prat fullname: Prat, Frédéric email: frederic.prat@aphp.fr organization: Gastroenterology unit, Hôpital Cochin (AP-HP), 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28567118$$D View this record in MEDLINE/PubMed https://hal.sorbonne-universite.fr/hal-03977411$$DView record in HAL |
| BookMark | eNp9Us2L1DAUL7LifujdkwS86KGadNKm9SAsy-oKA14UvJXX9LWTpZPUJB2d_9o_wVc67q4DeghJXn4fL8nvPDmxzmKSPBf8jRBKvRUqL7Jy9Y3WPONV8Sg5m0tpVsry5MH6NDkP4ZbzIlOr6klympV5oYQoz5Jf17Z1QbvRaDYN0UNwk23TfjIttmyDI0SjXQ8hehei2-7ZDn2YAhvR6ymCRUcb4tlwALPWg7HQI-ucZ1sYTG_BRtaYwYDfM9eQ1qSjcZZBF9GzDsxAZnjfiUey6z20yPTGDWB740aw2iPEuT5u9u8YLLAwIontkOFP6imagGkDgfRCnNo967zbsvjDMY2WzMLT5HEHQ8Bnh_ki-frh-svVTbr-_PHT1eU61bIqYto2istKN6jmwTvdFDJXIlc58KKoAKHRlWiLDJSUsuRKS8HzEnPkCkqhVxfJ-0V3nJottrO7h6EevdnSK9QOTP33iTWbune7OpeZLFVOAq8Xgc0R7eZyXc81vqqUkkLsBGFfHcy8-z5hiPXWBI3DsPxPLSq6DBcl5wR9eQS9dZO39BR1JjNRrThFiVAvHnZ_5_8nOATgC0DTDwSP3R1E8HrOZn2cTaIURxRtIsw5oPub4X_EdCEGStV9u__E_waVzf47 |
| CitedBy_id | crossref_primary_10_1007_s12328_021_01559_4 crossref_primary_10_1016_j_gie_2023_06_055 crossref_primary_10_1055_a_2282_3350 crossref_primary_10_1097_SLE_0000000000001192 crossref_primary_10_14309_crj_0000000000000704 crossref_primary_10_1055_s_0045_1805102 crossref_primary_10_1002_jhbp_823 crossref_primary_10_3390_diagnostics14232644 crossref_primary_10_1371_journal_pone_0275029 crossref_primary_10_1177_17562848221092612 crossref_primary_10_7759_cureus_23209 crossref_primary_10_1016_j_clinre_2019_02_014 crossref_primary_10_1097_eus_0000000000000055 crossref_primary_10_1007_s10620_022_07423_w crossref_primary_10_1016_j_clon_2023_05_004 crossref_primary_10_4103_EUS_D_21_00108 crossref_primary_10_1080_00365521_2022_2111228 crossref_primary_10_1177_2050640618808147 crossref_primary_10_1186_s12893_025_02807_x crossref_primary_10_1016_j_hpb_2020_06_001 crossref_primary_10_1055_a_1857_5775 crossref_primary_10_1159_000529089 crossref_primary_10_4251_wjgo_v13_i12_2050 crossref_primary_10_4253_wjge_v13_i10_473 crossref_primary_10_1055_s_0042_1757324 crossref_primary_10_1097_MOG_0000000000000857 crossref_primary_10_4240_wjgs_v17_i1_97596 crossref_primary_10_4103_EUS_D_22_00023 crossref_primary_10_1089_lap_2021_0587 crossref_primary_10_4253_wjge_v11_i2_103 crossref_primary_10_1002_jhbp_1165 crossref_primary_10_1007_s11894_018_0613_1 crossref_primary_10_3390_jcm13133883 crossref_primary_10_1111_den_14952 crossref_primary_10_1007_s00464_021_08653_1 crossref_primary_10_1016_j_dld_2018_09_015 crossref_primary_10_1007_s00464_020_08191_2 crossref_primary_10_1055_a_1717_1391 crossref_primary_10_1159_000500832 crossref_primary_10_14309_ajg_0000000000002190 crossref_primary_10_3389_fonc_2024_1370383 crossref_primary_10_1016_j_hbpd_2022_03_003 crossref_primary_10_1016_j_gie_2024_03_027 crossref_primary_10_1016_j_gie_2024_03_026 crossref_primary_10_1097_eus_0000000000000126 crossref_primary_10_3390_diagnostics13182933 |
| Cites_doi | 10.1016/j.gie.2008.11.003 10.1155/2012/348719 10.1016/j.gie.2015.10.033 10.1016/j.gie.2014.09.047 10.1136/bmj.330.7482.88 10.1055/s-2001-11186 10.1016/S1089-2516(01)90026-5 10.1016/j.giec.2012.04.009 10.1016/j.gie.2011.07.075 10.1097/MCG.0b013e31825f264c 10.1016/j.cgh.2015.12.032 10.1016/j.gie.2013.05.013 10.1016/j.gie.2011.08.032 10.1007/s00534-012-0577-8 10.1016/j.jamcollsurg.2007.10.003 10.1055/s-0029-1244082 10.1016/j.gie.2011.09.046 10.1177/2050640615601611 10.1055/s-0034-1391231 10.3748/wjg.v18.i32.4435 10.1007/s10620-014-3300-6 10.1055/s-0042-105647 10.1016/S0016-5107(99)70195-1 10.1055/s-2001-17324 10.1177/2050640613490928 10.1016/j.gie.2006.02.019 10.1016/j.gie.2013.03.004 10.1002/bjs.9260 10.1136/gut.13.12.1014 10.1007/s00270-014-0992-0 |
| ContentType | Journal Article |
| Copyright | The Author(s), 2017 The Author(s), 2017. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Distributed under a Creative Commons Attribution 4.0 International License The Author(s), 2017 2017 SAGE Publications |
| Copyright_xml | – notice: The Author(s), 2017 – notice: The Author(s), 2017. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: The Author(s), 2017 2017 SAGE Publications |
| DBID | AFRWT AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC 5PM |
| DOI | 10.1177/1756283X17702096 |
| DatabaseName | Sage Journals GOLD Open Access 2024 CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1756-2848 |
| EndPage | 493 |
| ExternalDocumentID | PMC5424875 oai:HAL:hal-03977411v1 28567118 10_1177_1756283X17702096 10.1177_1756283X17702096 |
| Genre | Journal Article |
| GroupedDBID | --- -TM 01A 0R~ 123 18M 29Q 4.4 53G 54M 5VS 7X7 8FI 8FJ AABMB AADUE AAJQC AAKDD AAQDB AARDL AARIX AASGM ABAWP ABEIX ABFWQ ABJIS ABKRH ABQXT ABRHV ABUWG ABVFX ACARO ACDSZ ACDXX ACGFS ACOFE ACROE ACRPL ADBBV ADEBD ADNMO ADOGD ADYCS ADZZY AENEX AEQLS AERKM AEUHG AEWDL AEXNY AFCOW AFEET AFKRA AFKRG AFRWT AFUIA AFWMB AGNHF AGQPQ AHHFK AJUZI ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS ARTOV ASPBG AUVAJ AVWKF AZFZN B8M BAWUL BCNDV BDDNI BENPR BKSCU BPHCQ BSEHC BVXVI CAG CCPQU CDWPY CFDXU COF CS3 DC- DC. DIK DOPDO E3Z EBS EJD EMOBN F5P FEDTE FYUFA GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GX1 H13 HF~ HMCUK HVGLF HYE HZ~ J8X K.F N9A O9- OK1 P.B PHGZM PHGZT PIMPY PQQKQ ROL RPM S01 SAUOL SCDPB SCNPE SFC UKHRP ZONMY ZPPRI ZRKOI ZSSAH AAYXX ACHEB AFFHD CITATION 31X AADTT AATBZ ACGZU ACSBE ACSIQ AEUIJ AEWHI B8Z DV7 M4V NPM SGV 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 1XC 5PM |
| ID | FETCH-LOGICAL-c496t-db7049cbe7cbe70fcb64571575a0669aeabc91d62a7444807c41058e5e07a81c3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 66 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000400907000005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1756-2848 1756-283X |
| IngestDate | Tue Nov 04 01:58:12 EST 2025 Tue Oct 14 20:43:52 EDT 2025 Thu Oct 02 05:56:01 EDT 2025 Tue Oct 07 06:41:53 EDT 2025 Thu Jan 02 22:20:49 EST 2025 Sat Nov 29 08:12:37 EST 2025 Tue Nov 18 22:04:06 EST 2025 Tue Jun 17 22:46:19 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | EUS pancreatic cancer ERCP jaundice PTBD |
| Language | English |
| License | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage). Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c496t-db7049cbe7cbe70fcb64571575a0669aeabc91d62a7444807c41058e5e07a81c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-2566-3866 |
| OpenAccessLink | https://www.proquest.com/docview/2421930702?pq-origsite=%requestingapplication% |
| PMID | 28567118 |
| PQID | 2421930702 |
| PQPubID | 4450843 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5424875 hal_primary_oai_HAL_hal_03977411v1 proquest_miscellaneous_1904901800 proquest_journals_2421930702 pubmed_primary_28567118 crossref_primary_10_1177_1756283X17702096 crossref_citationtrail_10_1177_1756283X17702096 sage_journals_10_1177_1756283X17702096 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-06-01 |
| PublicationDateYYYYMMDD | 2017-06-01 |
| PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London, England |
| PublicationPlace_xml | – name: London, England – name: England – name: London – name: Sage UK: London, England |
| PublicationTitle | Therapeutic advances in gastroenterology |
| PublicationTitleAlternate | Therap Adv Gastroenterol |
| PublicationYear | 2017 |
| Publisher | SAGE Publications Sage Publications Ltd Sage Publishing |
| Publisher_xml | – name: SAGE Publications – name: Sage Publications Ltd – name: Sage Publishing |
| References | Park 2012; 22 Fogel, Sherman, Devereaux 2001; 33 Winick, Waybill, Venbrux 2001; 4 Lee, Choi, Park 2016; 14 Khashab, Valeshabad, Afghani 2015; 60 Baron, Petersen, Mergener 2006; 63 Kao, Tyson, Blakely 2008; 206 Li, Bai, Qi 2015; 38 Kim, Gupta, Mallery 2010; 42 Giovannini, Bories 2012; 2012 Artifon, Aparicio, Paione 2012; 46 Khashab, Valeshabad, Modayil 2013; 78 Artifon, Marson, Gaidhane 2015; 81 Song, Hyun, Lee 2012; 18 Fang, Gurusamy, Wang 2013; 100 Khashab, Dewitt 2013; 78 Kawakubo, Kawakami, Kuwatani 2016; 48 Ekkelenkamp, de Man, Ter Borg 2015; 47 Khashab, El Zein, Sharzehi 2015; 3 Itoi, Yamao 2009; 69 Cotton 1972; 13 Wang, Zhu, Xing 2015; 83 Devereaux, Bhandari, Clarke 2005; 330 Isayama, Nakai, Kawakubo 2013; 20 Dhir, Bhandari, Bapat 2012; 75 Shah, Marson, Weilert 2012; 75 1999; 50 Bapaye, Dubale, Aher 2013; 1 Giovannini, Moutardier, Pesenti 2001; 33 Henry, Singh, Kalloo 2012; 76 Khashab MA (bibr26-1756283X17702096) 2015; 3 bibr29-1756283X17702096 bibr7-1756283X17702096 bibr16-1756283X17702096 bibr10-1756283X17702096 bibr3-1756283X17702096 bibr25-1756283X17702096 bibr23-1756283X17702096 Kawakubo K (bibr30-1756283X17702096) 2016; 48 bibr8-1756283X17702096 bibr17-1756283X17702096 bibr4-1756283X17702096 bibr22-1756283X17702096 bibr13-1756283X17702096 bibr18-1756283X17702096 bibr27-1756283X17702096 bibr9-1756283X17702096 bibr21-1756283X17702096 bibr14-1756283X17702096 bibr5-1756283X17702096 bibr1-1756283X17702096 bibr12-1756283X17702096 bibr6-1756283X17702096 bibr19-1756283X17702096 bibr15-1756283X17702096 bibr28-1756283X17702096 bibr20-1756283X17702096 bibr11-1756283X17702096 bibr2-1756283X17702096 bibr24-1756283X17702096 25590180 - Endoscopy. 2015 Jun;47(6):503-7 22248603 - Gastrointest Endosc. 2012 Feb;75(2):354-9 10644191 - Gastrointest Endosc. 1999 Dec;50(6):915-20 4568802 - Gut. 1972 Dec;13(12 ):1014-25 22197478 - Gastrointest Endosc. 2012 Nov;76(5):1065-7, 1067.e1-2 24917973 - United European Gastroenterol J. 2013 Aug;1(4):285-93 22632949 - Gastrointest Endosc Clin N Am. 2012 Apr;22(2):271-80, ix 26542374 - Gastrointest Endosc. 2016 Jun;83(6):1218-27 16564909 - Gastrointest Endosc. 2006 Apr;63(4 Suppl):S29-34 25081224 - Dig Dis Sci. 2015 Feb;60(2):557-65 11571690 - Endoscopy. 2001 Oct;33(10 ):898-900 24264780 - Br J Surg. 2013 Nov;100(12):1589-96 25500330 - Gastrointest Endosc. 2015 Apr;81(4):950-9 22018554 - Gastrointest Endosc. 2012 Jan;75(1):56-64 22969210 - World J Gastroenterol. 2012 Aug 28;18(32):4435-40 11748558 - Tech Vasc Interv Radiol. 2001 Sep;4(3):200-6 18222393 - J Am Coll Surg. 2008 Feb;206(2):361-9 25338831 - Cardiovasc Intervent Radiol. 2015 Jun;38(3):709-21 23886353 - Gastrointest Endosc. 2013 Nov;78(5):734-41 15637373 - BMJ. 2005 Jan 8;330(7482):88 23179560 - J Hepatobiliary Pancreat Sci. 2013 Apr;20(4):413-20 19179177 - Gastrointest Endosc. 2009 Feb;69(2 Suppl):S8-12 26748220 - Clin Gastroenterol Hepatol. 2016 Jul;14(7):1011-1019.e3 21860619 - Gastroenterol Res Pract. 2012;2012:348719 22810111 - J Clin Gastroenterol. 2012 Oct;46(9):768-74 23820411 - Gastrointest Endosc. 2013 Jul;78(1):102-5 20419625 - Endoscopy. 2010 Jun;42(6):496-502 11204985 - Endoscopy. 2001 Jan;33(1):31-8 26517848 - Endoscopy. 2016 Feb;48(2):164-9 |
| References_xml | – volume: 46 start-page: 768 year: 2012 end-page: 774 article-title: Biliary drainage in patients with unresectable, malignant obstruction where ERCP fails: endoscopic ultrasonography-guided choledochoduodenostomy versus percutaneous drainage publication-title: J Clin Gastroenterol – volume: 47 start-page: 503 year: 2015 end-page: 507 article-title: Prospective evaluation of ERCP performance: results of a nationwide quality registry publication-title: Endoscopy – volume: 18 start-page: 4435 year: 2012 end-page: 4440 article-title: Endoscopic ultrasound-guided choledochoduodenostomies with fully covered self-expandable metallic stents publication-title: World J Gastroenterol – volume: 76 start-page: 1065 year: 2012 end-page: 1067 article-title: Simultaneous EUS-guided transbulbar pancreaticobiliary drainage (with video) publication-title: Gastrointest Endosc – volume: 14 start-page: 1011 year: 2016 end-page: 1019.e3 article-title: Similar efficacies of endoscopic ultrasound-guided transmural and percutaneous drainage for malignant distal biliary obstruction publication-title: Clin Gastroenterol Hepatol – volume: 50 start-page: 915 year: 1999 end-page: 920 article-title: The role of ERCP in diseases of the biliary tract and pancreas. American Society for Gastrointestinal Endoscopy publication-title: Gastrointest Endosc – volume: 83 start-page: 1218 year: 2015 end-page: 1227 article-title: Assessment of efficacy and safety of EUS-guided biliary drainage: a systematic review publication-title: Gastrointest Endosc – volume: 78 start-page: 734 year: 2013 end-page: 741 article-title: EUS-guided biliary drainage by using a standardized approach for malignant biliary obstruction: rendezvous versus direct transluminal techniques (with videos) publication-title: Gastrointest Endosc – volume: 81 start-page: 950 year: 2015 end-page: 959 article-title: Hepaticogastrostomy or choledochoduodenostomy for distal malignant biliary obstruction after failed ERCP: is there any difference? publication-title: Gastrointest Endosc – volume: 330 start-page: 88 year: 2005 article-title: Need for expertise based randomised controlled trials publication-title: Br Med J – volume: 69 start-page: S8 year: 2009 end-page: S12 article-title: EUS 2008 Working Group document: evaluation of EUS-guided choledochoduodenostomy (with video) publication-title: Gastrointest Endosc – volume: 4 start-page: 200 year: 2001 end-page: 206 article-title: Complications of percutaneous transhepatic biliary interventions publication-title: Tech Vasc Interv Radiol – volume: 22 start-page: 271 year: 2012 end-page: 280 article-title: Endoscopic ultrasonography-guided hepaticogastrostomy publication-title: Gastrointest Endosc Clin N Am – volume: 48 start-page: 164 year: 2016 end-page: 169 article-title: Endoscopic ultrasound-guided choledochoduodenostomy vs. transpapillary stenting for distal biliary obstruction publication-title: Endoscopy – volume: 2012 start-page: 348719 year: 2012 article-title: EUS-guided biliary drainage publication-title: Gastroenterol Res Pract – volume: 75 start-page: 354 year: 2012 end-page: 359 article-title: Comparison of EUS-guided rendezvous and precut papillotomy techniques for biliary access (with videos) publication-title: Gastrointest Endosc – volume: 206 start-page: 361 year: 2008 end-page: 369 article-title: Clinical research methodology I: introduction to randomized trials publication-title: J Am Coll Surg – volume: 20 start-page: 413 year: 2013 end-page: 420 article-title: The endoscopic ultrasonography-guided rendezvous technique for biliary cannulation: a technical review publication-title: J Hepato-Biliary-Pancreat Sci – volume: 1 start-page: 285 year: 2013 end-page: 293 article-title: Comparison of endosonography-guided vs. percutaneous biliary stenting when papilla is inaccessible for ERCP publication-title: United Eur Gastroenterol J – volume: 63 start-page: S29 year: 2006 end-page: S34 article-title: Quality indicators for endoscopic retrograde cholangiopancreatography publication-title: Gastrointest Endosc – volume: 60 start-page: 557 year: 2015 end-page: 565 article-title: A comparative evaluation of EUS-guided biliary drainage and percutaneous drainage in patients with distal malignant biliary obstruction and failed ERCP publication-title: Dig Dis Sci – volume: 13 start-page: 1014 year: 1972 end-page: 1025 article-title: Cannulation of the papilla of Vater by endoscopy and retrograde cholangiopancreatography (ERCP) publication-title: Gut – volume: 100 start-page: 1589 year: 2013 end-page: 1596 article-title: Meta-analysis of randomized clinical trials on safety and efficacy of biliary drainage before surgery for obstructive jaundice publication-title: Br J Surg – volume: 38 start-page: 709 year: 2015 end-page: 721 article-title: Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center publication-title: Cardiovasc Intervent Radiol – volume: 3 start-page: 1 year: 2015 end-page: 145 article-title: nternational multicenter comparative trial of EUS-guided biliary drainage vs. enteroscopy-assisted ERCP in patients with surgical anatomy and biliary obstruction publication-title: United Eur Gastroenterol J – volume: 42 start-page: 496 year: 2010 end-page: 502 article-title: Endoscopic ultrasound rendezvous for bile duct access using a transduodenal approach: cumulative experience at a single center. A case series publication-title: Endoscopy – volume: 75 start-page: 56 year: 2012 end-page: 64 article-title: Single-operator, single-session EUS-guided anterograde cholangiopancreatography in failed ERCP or inaccessible papilla publication-title: Gastrointest Endosc – volume: 33 start-page: 898 year: 2001 end-page: 900 article-title: Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage publication-title: Endoscopy – volume: 78 start-page: 102 year: 2013 end-page: 105 article-title: EUS-guided biliary drainage: is it ready for prime time? Yes! publication-title: Gastrointest Endosc – volume: 33 start-page: 31 year: 2001 end-page: 38 article-title: Therapeutic biliary endoscopy publication-title: Endoscopy – ident: bibr18-1756283X17702096 doi: 10.1016/j.gie.2008.11.003 – ident: bibr29-1756283X17702096 doi: 10.1155/2012/348719 – ident: bibr20-1756283X17702096 doi: 10.1016/j.gie.2015.10.033 – ident: bibr19-1756283X17702096 doi: 10.1016/j.gie.2014.09.047 – ident: bibr28-1756283X17702096 doi: 10.1136/bmj.330.7482.88 – ident: bibr3-1756283X17702096 doi: 10.1055/s-2001-11186 – ident: bibr7-1756283X17702096 doi: 10.1016/S1089-2516(01)90026-5 – ident: bibr12-1756283X17702096 doi: 10.1016/j.giec.2012.04.009 – ident: bibr10-1756283X17702096 doi: 10.1016/j.gie.2011.07.075 – ident: bibr21-1756283X17702096 doi: 10.1097/MCG.0b013e31825f264c – ident: bibr24-1756283X17702096 doi: 10.1016/j.cgh.2015.12.032 – ident: bibr14-1756283X17702096 doi: 10.1016/j.gie.2013.05.013 – ident: bibr13-1756283X17702096 doi: 10.1016/j.gie.2011.08.032 – ident: bibr9-1756283X17702096 doi: 10.1007/s00534-012-0577-8 – ident: bibr27-1756283X17702096 doi: 10.1016/j.jamcollsurg.2007.10.003 – ident: bibr15-1756283X17702096 doi: 10.1055/s-0029-1244082 – ident: bibr17-1756283X17702096 doi: 10.1016/j.gie.2011.09.046 – volume: 3 start-page: 1 year: 2015 ident: bibr26-1756283X17702096 publication-title: United Eur Gastroenterol J doi: 10.1177/2050640615601611 – ident: bibr4-1756283X17702096 doi: 10.1055/s-0034-1391231 – ident: bibr11-1756283X17702096 doi: 10.3748/wjg.v18.i32.4435 – ident: bibr23-1756283X17702096 doi: 10.1007/s10620-014-3300-6 – volume: 48 start-page: 164 year: 2016 ident: bibr30-1756283X17702096 publication-title: Endoscopy doi: 10.1055/s-0042-105647 – ident: bibr2-1756283X17702096 doi: 10.1016/S0016-5107(99)70195-1 – ident: bibr8-1756283X17702096 doi: 10.1055/s-2001-17324 – ident: bibr22-1756283X17702096 doi: 10.1177/2050640613490928 – ident: bibr5-1756283X17702096 doi: 10.1016/j.gie.2006.02.019 – ident: bibr16-1756283X17702096 doi: 10.1016/j.gie.2013.03.004 – ident: bibr25-1756283X17702096 doi: 10.1002/bjs.9260 – ident: bibr1-1756283X17702096 doi: 10.1136/gut.13.12.1014 – ident: bibr6-1756283X17702096 doi: 10.1007/s00270-014-0992-0 – reference: 20419625 - Endoscopy. 2010 Jun;42(6):496-502 – reference: 11571690 - Endoscopy. 2001 Oct;33(10 ):898-900 – reference: 11204985 - Endoscopy. 2001 Jan;33(1):31-8 – reference: 4568802 - Gut. 1972 Dec;13(12 ):1014-25 – reference: 18222393 - J Am Coll Surg. 2008 Feb;206(2):361-9 – reference: 23179560 - J Hepatobiliary Pancreat Sci. 2013 Apr;20(4):413-20 – reference: 22248603 - Gastrointest Endosc. 2012 Feb;75(2):354-9 – reference: 24264780 - Br J Surg. 2013 Nov;100(12):1589-96 – reference: 11748558 - Tech Vasc Interv Radiol. 2001 Sep;4(3):200-6 – reference: 21860619 - Gastroenterol Res Pract. 2012;2012:348719 – reference: 22632949 - Gastrointest Endosc Clin N Am. 2012 Apr;22(2):271-80, ix – reference: 22197478 - Gastrointest Endosc. 2012 Nov;76(5):1065-7, 1067.e1-2 – reference: 26748220 - Clin Gastroenterol Hepatol. 2016 Jul;14(7):1011-1019.e3 – reference: 26517848 - Endoscopy. 2016 Feb;48(2):164-9 – reference: 25081224 - Dig Dis Sci. 2015 Feb;60(2):557-65 – reference: 22810111 - J Clin Gastroenterol. 2012 Oct;46(9):768-74 – reference: 25338831 - Cardiovasc Intervent Radiol. 2015 Jun;38(3):709-21 – reference: 25590180 - Endoscopy. 2015 Jun;47(6):503-7 – reference: 10644191 - Gastrointest Endosc. 1999 Dec;50(6):915-20 – reference: 26542374 - Gastrointest Endosc. 2016 Jun;83(6):1218-27 – reference: 16564909 - Gastrointest Endosc. 2006 Apr;63(4 Suppl):S29-34 – reference: 25500330 - Gastrointest Endosc. 2015 Apr;81(4):950-9 – reference: 23886353 - Gastrointest Endosc. 2013 Nov;78(5):734-41 – reference: 22969210 - World J Gastroenterol. 2012 Aug 28;18(32):4435-40 – reference: 22018554 - Gastrointest Endosc. 2012 Jan;75(1):56-64 – reference: 24917973 - United European Gastroenterol J. 2013 Aug;1(4):285-93 – reference: 19179177 - Gastrointest Endosc. 2009 Feb;69(2 Suppl):S8-12 – reference: 23820411 - Gastrointest Endosc. 2013 Jul;78(1):102-5 – reference: 15637373 - BMJ. 2005 Jan 8;330(7482):88 |
| SSID | ssj0062739 |
| Score | 2.3611946 |
| Snippet | Background:
Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of... Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of the common... Background: Percutaneous transhepatic biliary drainage (PTBD) is widely performed as a salvage procedure in patients with unresectable malignant obstruction of... |
| SourceID | pubmedcentral hal proquest pubmed crossref sage |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 483 |
| SubjectTerms | Bile Endoscopy Gastroenterology Life Sciences Original Research Pancreatic cancer Success Ultrasonic imaging |
| Title | Endoscopic ultrasound-guided hepaticogastrostomy versus percutaneous transhepatic drainage for malignant biliary obstruction after failed endoscopic retrograde cholangiopancreatography: a retrospective expertise-based study from two centers |
| URI | https://journals.sagepub.com/doi/full/10.1177/1756283X17702096 https://www.ncbi.nlm.nih.gov/pubmed/28567118 https://www.proquest.com/docview/2421930702 https://www.proquest.com/docview/1904901800 https://hal.sorbonne-universite.fr/hal-03977411 https://pubmed.ncbi.nlm.nih.gov/PMC5424875 |
| Volume | 10 |
| WOSCitedRecordID | wos000400907000005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1756-2848 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062739 issn: 1756-2848 databaseCode: 7X7 dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1756-2848 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062739 issn: 1756-2848 databaseCode: BENPR dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1756-2848 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062739 issn: 1756-2848 databaseCode: PIMPY dateStart: 20170101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB6RFCEu5VkwlGpACImDldixvTYXVFCqIrVRhACFk7Xe3Tyk1g55tOq_5icws94kDRW9cMjL3iizzuedb3ZnvwF4a3RSpKKjfTmMKUDRnY5fpFL6Kop0ZkSkCitf_ONE9HrpYJD13YTb3KVVrsZEO1DrSvEceYuXLjMGaPhx-svnqlG8uupKaDRgh5XKoibsfOr2-l9XY3FCzjmzWyLjxCdHOtgsVLb4GB-i90SZWLT_mmNqjDkt8ibnvJk6eS3_y7qkowf_25mHsOvIKB7W6HkEd0z5GO6duuX2J_C7W-qK961MFC7PyJI5F2HyR8uJNhrHhrOxVTWS8wXvHanOr5CTPJZznJqZWhLtNBV9WLA7dI1Rc0kK6gsSWcZzCgJGnImDnKIrZ1dYFWtBW7Tly3EoadzSaDaWzMzCJpVpgzYyL0cTivzLegKhFuD-gLJuttpIiraSARee9tlva7Syusiba3BxWSFfaDL9KXw_6n77fOy7EhEEpixZ-LoQFOKowgh-tIeqSKJYBMRBJXGpTBpZqCzQSShFFPHuecVpramJTVvINFCdPWiWVWmeAxLTiVNNMIqikFhVmiY6Jv6rawEcMfSgtcJHrpx-OpfxOMsDJ5n-N6I8eL_-xrTWDrml7RuC3LoZi34fH57kfKxtOXoQXAQe7K_glLuhZp5vsOTB6_VpGiR45af-o3NifVHGUm1tD57VAF7_VJjGiaAw0wOxBe0tW7bPlJOxFSKP6UpRvOvBO74JNib9q5Mvbrf_JdwPmTTZOa59aBLezCu4qy4IHbMDaIiBsM_pgbvN6bX_5bT_8w8r518z |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD7aOgS8cL8EBhgESDxEbdIkTpAQmmBTq7VVHwbqnoJjuxdpS0qbbuqf4rfxEzjHSdqVib3tgYdKreMmjv35-Dv2uQC81SpIQt5Uthj6qKCoZtNOQiFs6Xkq0tyTiQlf_L3De71wMIj6W_Cr8oUhs8pKJhpBrTJJe-R1OrqMCKDu5-lPm7JG0elqlUKjgMWhXp6jyjb_1P6K4_vOdQ_2j7607DKrAD4_CnJbJRxZsUw0p09jKJPA87mDtEXg8hsJLRIZOSpwBfc8criWZAkZal83uAgd2cT7bsOOh2APa7DTb3f7x5XsD5AMRMYF0w9sXLgH64PROpVREX5HikZJAi4shNtjMsO8zHEvm2pesDczS-DB3f-t8-7BnZJss71idtyHLZ0-gJvd0pzgIfzeT1VGfjkTyRYn-OZzSjJljxYTpRUba7I2l9lIzHPyjclOl4yMWBZzNtUzuUBarTP8kdNyX1ZmilJuYN8xVAbYKSo5I7I0YmSCLGZLliWrgL3MpGdnQ4FyWTG9bslM58ZoTmlmdh7S0SRDmV1skBQBxj8yUVSrHGWZydRAibVt4iWKmbDBjJyHWH6eMRpYbPoj-HYt_f0YammW6qfAkMn5oUJ9H5GLrDEMA-Ujv1dFgB8-tKBe4TGWZXx4SlNyEjtlSPi_EWzBh9U_pkVslCvqvkGIr6pRUPPWXiemsobRQRznzLFgt4JvXIrSebzGrgWvV5dRCNLJVjHQMbJaL6JQdA0LnhQTZvUoN_QDjmq0BXxjKm20ZfNKOhmbQOs-9hTq8xa8p0m3btK_XvLZ1e1_BbdaR91O3Gn3Dp_DbZcIotnP24UaYk-_gBvyDJEye1mKFQY_rnsy_gED9LiN |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endoscopic+ultrasound-guided+hepaticogastrostomy+versus+percutaneous+transhepatic+drainage+for+malignant+biliary+obstruction+after+failed+endoscopic+retrograde+cholangiopancreatography%3A+a+retrospective+expertise-based+study+from+two+centers&rft.jtitle=Therapeutic+advances+in+gastroenterology&rft.au=Sportes+Adrien&rft.au=Camus+Marine&rft.au=Greget+Michel&rft.au=Leblanc%2C+Sarah&rft.date=2017-06-01&rft.pub=Sage+Publications+Ltd&rft.issn=1756-283X&rft.eissn=1756-2848&rft.volume=10&rft.issue=6&rft.spage=483&rft.epage=493&rft_id=info:doi/10.1177%2F1756283X17702096 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-2848&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-2848&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-2848&client=summon |